معرفی
Dr. Geoffrey Chupp is a Professor of Medicine in the Yale School of Medicine's Department of Pulmonary, Critical Care & Sleep Medicine. He directs the Yale Center for Asthma and Airways Disease (YCAAD), a multidisciplinary program focusing on severe asthma and airway diseases. His research explores biomarkers like YKL-40 and molecular phenotyping to improve asthma treatment. He leads clinical trials evaluating biologics such as mepolizumab and tezepelumab. Educated at Tufts University and George Washington University School of Medicine, he has been recognized with awards including Connecticut Magazine's Top Docs and the Yale Technology Summit Innovation Award.
Education:
- Bachelor's Degree: Tufts University (1986)
- MD: George Washington University School of Medicine (1990)
- Residency: Tufts University School of Medicine (1993)
- Fellowship: Boston University School of Medicine (1997)
Research Focus: Asthma pathogenesis, chitinase biology, biomarker discovery, precision medicine approaches for severe airway diseases, and translational clinical trials.
Awards:
- Yale Technology Summit Second Place (2017)
- Connecticut Top Docs (2015-2016)
- Yale New Haven Hospital Distinguished Service Award (2008)
Key Programs: Director of YCAAD and the Pulmonary Function Laboratory at Yale-New Haven Hospital. Principal Investigator for NIH-funded studies on CHI3L1 genetics and asthma severity.
Clinical Trials: Active trials include the REALITI-A mepolizumab study and NAVIGATOR tezepelumab trials, focusing on severe asthma management and biomarker-guided therapies.
Labs & Teams: Chupp Lab at the Anlyan Center, collaborating with teams like the Center for Precision Pulmonary Medicine and the Tuberculosis Program.